# | Title | Journal | Year | Citations |
---|
|
1 | Whole genomes redefine the mutational landscape of pancreatic cancer | Nature | 2015 | 2,204 |
2 | Margin Clearance and Outcome in Resected Pancreatic Cancer | Journal of Clinical Oncology | 2009 | 301 |
3 | Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel | Journal of Clinical Oncology | 2009 | 281 |
4 | PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality | International Journal of Cancer | 2010 | 262 |
5 | Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers | Proceedings of the National Academy of Sciences of the United States of America | 2010 | 259 |
6 | Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial | Clinical Cancer Research | 2015 | 211 |
7 | Hypermutation In Pancreatic Cancer | Gastroenterology | 2017 | 180 |
8 | DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma | Journal of Clinical Oncology | 2002 | 154 |
9 | Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer | Cancer Research | 2011 | 153 |
10 | Cytoplasmic Localization of β-Catenin is a Marker of Poor Outcome in Breast Cancer Patients | Cancer Epidemiology Biomarkers and Prevention | 2010 | 141 |
11 | DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer | Nature Communications | 2015 | 113 |
12 | Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation | Cell Reports | 2016 | 111 |
13 | Low Microsatellite Instability Is Associated With Poor Prognosis in Stage C Colon Cancer | Journal of Clinical Oncology | 2005 | 110 |
14 | miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense | Cancer Research | 2018 | 109 |
15 | Clinical and molecular characterization of HER2 amplified-pancreatic cancer | Genome Medicine | 2013 | 101 |
16 | Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach | PLoS ONE | 2015 | 91 |
17 | A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma | American Journal of Surgical Pathology | 2015 | 88 |
18 | Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features | American Journal of Surgical Pathology | 2019 | 80 |
19 | Prognostic Significance of Pathologic Features in Localized Prostate Cancer Treated With Radical Prostatectomy: Implications for Staging Systems and Predictive Models | Journal of Clinical Oncology | 2001 | 77 |
20 | Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition | Cancer Research | 2021 | 72 |
21 | β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression | Cancer Research | 2013 | 70 |
22 | Effects of Mechanical Stress and Carvedilol in Lamin A/C–Deficient Dilated Cardiomyopathy | Circulation Research | 2010 | 64 |
23 | Adjuvant chemotherapy in elderly patients with pancreatic cancer | British Journal of Cancer | 2014 | 64 |
24 | ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells | PLoS Biology | 2015 | 60 |
25 | Recruitment and Activation of Pancreatic Stellate Cells from the Bone Marrow in Pancreatic Cancer: A Model of Tumor-Host Interaction | PLoS ONE | 2011 | 58 |
26 | Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities | Expert Reviews in Molecular Medicine | 2015 | 53 |
27 | High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype | Histopathology | 2010 | 51 |
28 | ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype | Nature Communications | 2015 | 51 |
29 | Precision Oncology in Surgery | Annals of Surgery | 2020 | 49 |
30 | ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors | Human Pathology | 2018 | 42 |
31 | Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma | Clinical Cancer Research | 2014 | 33 |
32 | Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status | Science Advances | 2021 | 31 |
33 | Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer—a potential diagnostic pitfall | Histopathology | 2009 | 22 |
34 | TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up | Cancers | 2020 | 22 |
35 | MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer | International Journal of Radiation Oncology Biology Physics | 2015 | 18 |
36 | The epithelioid BAP1‐negative and p16‐positive phenotype predicts prolonged survival in pleural mesothelioma | Histopathology | 2018 | 17 |
37 | Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status | International Journal of Cancer | 2010 | 16 |
38 | Gene Based Prediction of Clinically Localized Prostate Cancer Progression After Radical Prostatectomy | Journal of Urology | 2010 | 15 |
39 | LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness | Oncotarget | 2017 | 14 |
40 | Synchronous Nesidioblastosis, Endocrine Microadenoma, and Intraductal Papillary Mucinous Neoplasia in a Man Presenting With Hyperinsulinemic Hypoglycemia | Pancreas | 2016 | 11 |
41 | The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer | Annals of Surgery | 2023 | 11 |
42 | LMO4 expression in squamous cell carcinoma of the anterior tongue | Histopathology | 2011 | 9 |
43 | BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma | Pathology | 2018 | 9 |
44 | Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease | PLoS ONE | 2009 | 8 |
45 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes | Clinical Cancer Research | 2022 | 8 |
46 | The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma | Diseases (Basel, Switzerland) | 2018 | 7 |
47 | Individualizing therapy for pancreatic cancer | Journal of Gastroenterology and Hepatology (Australia) | 2008 | 6 |
48 | Monoclonal precursor T-cell infiltrate in recurrent thymoma: a case report | Pathology | 2015 | 2 |
49 | MCP‐1 expression in breast cancer and its association with distant relapse | Cancer Medicine | 2023 | 2 |
50 | LOSS OF ESTROGEN RECEPTOR-beta (ERbeta) IN PROSTATE CANCER | Pathology International | 2001 | 0 |